| ICU | NTHI | ICU / NTHI | |
| Capitalization | 15.6M | 93.9M | 17% |
| EBITDA | -13.6M | -43.76M | 31% |
| Gain YTD | 49.167 | -59.734 | -82% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 1.71M | 40K | 4,283% |
| Total Cash | 6.96M | 1.97M | 353% |
| Total Debt | 134K | 328K | 41% |
| ICU | NTHI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 60% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 80% | 9 days ago 88% |
| Declines ODDS (%) | 21 days ago 89% | 7 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 57% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICU’s FA Score shows that 1 FA rating(s) are green while NTHI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICU’s TA Score shows that 4 TA indicator(s) are bullish while NTHI’s TA Score has 4 bullish TA indicator(s).
ICU (@Biotechnology) experienced а +17.38% price change this week, while NTHI (@Biotechnology) price change was -11.90% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.01%. For the same industry, the average monthly price growth was -6.79%, and the average quarterly price growth was +7.55%.
ICU is expected to report earnings on Nov 18, 2026.
NTHI is expected to report earnings on Nov 13, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JDPNX | 16.15 | 0.01 | +0.06% |
| Janus Henderson Mid Cap Value N | |||
| GQFIX | 13.41 | N/A | N/A |
| GQG Partners Global Quality Value Fd Ins | |||
| ELMFX | 26.28 | N/A | N/A |
| Lord Abbett Emerging Markets Equity F | |||
| FIQCX | 34.35 | N/A | N/A |
| Fidelity Advisor Asset Manager 85% Z | |||
| RSIRX | 15.90 | N/A | N/A |
| Victory RS International R6 | |||
A.I.dvisor indicates that over the last year, ICU has been closely correlated with CANF. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICU jumps, then CANF could also see price increases.
| Ticker / NAME | Correlation To ICU | 1D Price Change % | ||
|---|---|---|---|---|
| ICU | 100% | +1.13% | ||
| CANF - ICU | 93% Closely correlated | -0.89% | ||
| APVO - ICU | 85% Closely correlated | -1.63% | ||
| GNPX - ICU | 82% Closely correlated | +0.87% | ||
| TNXP - ICU | 77% Closely correlated | -1.38% | ||
| LONA - ICU | 62% Loosely correlated | -6.77% | ||
More | ||||
A.I.dvisor tells us that NTHI and NTRB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTHI and NTRB's prices will move in lockstep.
| Ticker / NAME | Correlation To NTHI | 1D Price Change % | ||
|---|---|---|---|---|
| NTHI | 100% | +2.15% | ||
| NTRB - NTHI | 30% Poorly correlated | -4.43% | ||
| CLRB - NTHI | 25% Poorly correlated | -1.26% | ||
| DMAC - NTHI | 24% Poorly correlated | +5.99% | ||
| ABVC - NTHI | 24% Poorly correlated | -0.86% | ||
| IBO - NTHI | 22% Poorly correlated | -5.81% | ||
More | ||||